Brief: Eckert & Ziegler Gains Approval For Galliapharm® In Japan
Sept 19 (Reuters) - ECKERT & ZIEGLER SE EUZG.DE: GAINS APPROVAL FOR GALLIAPHARM® IN JAPAN AUTHORIZATION ALLOWS BROADER USE OF GALLIUM-68 DIAGNOSTICS IN JAPAN Source text: ID:nEQ3sY6CLa Further company coverage: EUZG.DE (Gdansk Newsroom) ((((gdansk.newsroom@thomsonreuters.com ; +48 587785269; ));))
Recent news on Eckert & Ziegler SE
See all newsBrief: Eckert & Ziegler Brazil And Terthera Sign Supply Agreement For Terbium-161
Germany's Eckert & Ziegler H1 net income rises, confirms FY view
Brief: Eckert & Ziegler - FY Outlook Confirmed
Brief: Eckert & Ziegler: BaFin Questions Pentixapharm Spin-Off Accounting at Eckert & Ziegler
Germany's Eckert & Ziegler Q1 sales rise on medical segment growth